Clinical study of docetaxel combined with concurrent radiotherapy in patients with advanced nasopharyngeal carcinoma

Chinese-German Journal of Clinical Oncology

Volumn 12, Issue 12, 2013, Pages

  Luo, Wei ^a   Ge, Wei ^a   Zheng, Yongfa ^a   Pan, Xianfeng ^a   Song, Jing ^a   Xu, Huilin ^a   Ming, Pingpo ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Concurrent radiotherapy; Docetaxel (DOC); Nasopharyngeal carcinoma

Indexed keywords

ALANINE AMINOTRANSFERASE; CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLERGY; ARTICLE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DERMATITIS; DIARRHEA; DRUG EFFICACY; DRUG RESPONSE; ECG ABNORMALITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; IRON DEFICIENCY ANEMIA; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NAUSEA AND VOMITING; NEUROTOXICITY; NEUTROPENIA; ORAL MUCOSITIS; RADIATION DOSE; REMISSION; THROMBOCYTOPENIA; TOXICITY; TREATMENT DURATION; WEIGHT REDUCTION; X RAY; YOUNG ADULT;

EID: 84893049768     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/s10330-013-1252-5     Document Type: Article

References (13)

1. Ma J. Research on treatment for nasopharyngeal carcinoma. J SUN Yat-sen Univ (Med Sci) (Chinese), 2010, 13: 179-182.
2. Yin WB, Yu ZH, Xu GZ, et al. Radiation oncology. Bei Jing: Peking Union Medical College Press, 2008. 477-480.
3. Ma J, Mai HQ, Hong MH, el al. Long-term resuits of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapv alone for patients with locoregionally advanced nasopharyngeal carcinoma. Chin J Cancer (Chinese), 2001, 20: 505-510.
4. Chen Y, Sun Y, Liang SB, et al. Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China. Cancer, 2013, 119: 2230-2238.
5. Zhang L, Zhao C, Ghimire B, et al. The role of current chemotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials. BMC cancer, 2010, 10: 558.
6. Perri F, Della Vittoria Scarpati G, Buonerba C, et al. Combined chemoradiotherapy in locally advanced nasopharyngeal carcinomas. World J Clin Oncol, 2013, 4: 47-51.
7. Li DJ, Xu XH, Xue F, et al. Clinical observation of DC combined with concurrent chemoradiotherapy in curing locally advanced nasopharyngeal carcinoma. DC Shandong Med J (Chinese), 2008, 48: 78-79.
8. Ma DY, Fu CQ, Tan BX, et al. Radiation therapy concurrent with weekly cisplatin therapy for loco-regionally advanced nasopharyngeal carcinoma: outcomes of a clinical trial. Chinese-German J Clin Oncol, 2011, 10: 187-191.
9. Zhao YF, Zhang HY, Cheng Y, et al. Weekly dose cisplatin concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma. J Oncol (Chinese), 2009, 15: 127-129.
10. Hu F, Deng GZ, Wu XT, et al. PF regimen combined with concurrent radiotherapy for stage III nasopharyngeal caricinoma. J cancer contr treat (Chinese), 2010, 23: 483-485.
11. Lu X, Guo X, Hong MH, et al. Comparison of the short-term efficacy of two inductive chemotherapy regimens for locally advanced nasopharyngeal caricinoma: docetaxal plus carboplatin versus 5-fluorouracil plus carboplatin. Chin J Cancer, 2010, 29: 140-144.
12. Wu X, Huang PY, Peng PJ, et al. Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma. Ann Oncol, 2013, 24: 2131-2136.
13. Perri F, Della Vittoria Scarpati G, Buonerba C, et al. Combined chemoradiotherapy in locally advanced nasopharyngeal carcinomas. World J Clin Oncol, 4: 47-51.